Vous êtes ici : Accueil > Actualites > 3rd GENMED Workshop on Medical Genomics - 17th & 18th May 2018

Séminaire | Génomique

GENMED Partners Workshop

3rd GENMED Workshop on Medical Genomics - 17th & 18th May 2018


The workshop on Medical Genomics aims at uniting the genomic community over two days and will include talks from GENMED partners who will present their latest results in human disease genomics. 

Publié le 17 mai 2018
The workshop on Medical Genomics aims at uniting the genomic community over two days and will include talks from GENMED partners who will present their latest results in human disease genomics. 

In addition, internationally renowned speakers will be invited to give general presentations covering broader and innovative topics in the field of “omic” research. The presentations will be grouped into a number of themed sessions presided by chairs that will ensure discussion and interaction of participants, a key component of the workshop. In addition time will be dedicated to ethical considerations when performing genomic research.

Coordinated by Drs. Jean-François Deleuze & François Cambien, the Laboratory of Excellence (LabEx) MEDical GENomics - GENMED – involves the collaboration between CEPH, CEA-CNRGH, Inserm/UPMC. This Labex is funded through the French National Research Agency (ANR) Investissement d'avenir programme. 

GENMED aims to promote the development of competitive research projects in human diseases both nationally & internationally in the context of Medical Genomics by evaluating, developing and implementing NGS based technologies and methodologies together with integrated analysis of genomic data in a high-throughput production mode. In addition GENMED is involved in education and training initiatives as well as promoting ethical aspects in order to build structural foundations to implement and develop Medical Genomics in France and beyond.

Confirmed Speakers Include: Fabrice ANDRE (Institut Gustave Roussy, Paris, FR), Johan BJORKEGREN (Karolinska Institutet, Stockholm, SE), Alessandro
BLASSIME (ETH, Zurich, CH), Thomas BOURGERON (Institut Pasteur, Paris, FR), Mark CAULFIELD (Queen Mary University of London, UK), François Cornu (eurofin-Biomnis, FR) Jean-François DELEUZE (CEA-CNRGH/CEPH, Evry, FR), Evan EICHLER (University of Washington, US), Henri-Jean GARCHON (INSERMUVSQ, FR), Sophie GARNIER (INSERM/UPMC, Paris, FR), Emmanuelle GENIN (INSERM, Brest, FR), Jean-Charles LAMBERT (Institut Pasteur, Lille, FR), Yves LEVY (INSERM-AVIESAN, Paris, FR), Yang LI (The University of Chicago, US), Brian LOCKHART, (SERVIER, Suresnes, FR), Pierre MORANGE (INSERM-Hôpital de la Timone, Marseille, FR), David-Alexandre TREGOUET (INSERM/UPMC, Paris, FR), Jean-Philippe VERT (Mines ParisTech, FR).



Haut de page